Biochemical markers of endothelial activation in primary hyperparathyroidism

Hormone and Metabolic Research

Volumn 38, Issue 2, 2006, Pages 125-129

  Fallo, F ^a   Cella, G ^a   Casonato, A ^a   Ermani, M ^a   Vettor, R ^a   Zanella, S ^a   Lumachi, F ^a  

^a UNIVERSITY OF PADOVA   (Italy)

Author keywords

Endothelium; Primary hyperparathyroidism; Von Willebrand factor

Indexed keywords

CALCIUM; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; PARATHYROID HORMONE; THROMBOMODULIN; VON WILLEBRAND FACTOR;

ADULT; AGED; ARTICLE; CALCIUM TRANSPORT; CARDIOVASCULAR RISK; CLINICAL ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; ENDOTHELIUM; FEMALE; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; MALE; OBESITY; PARATHYROID HORMONE RELEASE; PARATHYROIDECTOMY; PRIMARY HYPERPARATHYROIDISM; PRIORITY JOURNAL; SMOKING; VASODILATATION;

BIOLOGICAL MARKERS; CARDIOVASCULAR DISEASES; E-SELECTIN; ENDOTHELIUM, VASCULAR; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPERPARATHYROIDISM, PRIMARY; MALE; MIDDLE AGED; PARATHYROIDECTOMY; RISK FACTORS; THROMBOMODULIN; VASODILATION; VON WILLEBRAND FACTOR;

EID: 33645715645     PISSN: 00185043     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2006-925135     Document Type: Article

References (42)

1. Hedback G, Oden A. The increased risk of death of primary hyperparathyroidism-an update. Eur J Clin Invest 1998; 28: 271-276
2. Silverberg SJ, Shane E, Jacobs TP, Siris E, Bilezikian JP. The natural history of treated and untreated asymptomatic primary hyperparathyroidism. N Engl J Med 1999; 341: 1249-1255
3. Fallo F, Camporese G, Capitelli E, Andreozzi GM, Mantero F, Lumachi F. Ultrasound evaluation of carotid artery in primary hyperparathyroidism. J Clin Endocrinol Metab 2003; 88: 2096-2099
4. Lumachi E, Ermani M, Luisetto G, Nardi A, Basso SMM, Camozzi V, Favia G. Relationship between serum parathyroid hormone, serum calcium and arterial blood pressure in patients with primary hyperparathyroidism: results of a multivariate analysis. Eur J Endocrinol 2002; 146: 643-647
5. Garcia de la Torre N, Wass JAH, Turner HE. Parathyroid adenomas and cardiovascular risk. Endocr-Relat Cancer 2003; 10: 309-322
6. Nillson IL, Aberg JA, Rastad J, Lind L. Endothelial vasodilatory dysfunction in primary hyperparathyroidism is reversed after parathyroidectomy. Surgery 1999; 126: 1049-1055
7. Kosch M, Hausberg M, Vormbrock K, Kisters K, Rahn KH, Barenbrock MK. Studies on flow-mediated vasodilation and intima-media thickness of the brachial artery in patients with primary hyperparathyroidism. Am J Hypertens 2000; 13: 759-764
8. Nillson IL, Rastad J, Johansson K, Lind L. Endothelial vasodilatory function and blood pressure response to local and systemic hypercalcemia. Surgery 2001; 130: 986-990
9. Neunteufl T, Katzenschlager R, Abela C, Kostner K, Niederle B, Weidinger F, Stefenelli T. Impairment of endothelium-independent vasodilation in patients with hypercalcemia. Cardiovasc Res 1998; 40: 396-401
10. Neunteufl T, Heher S, Prager G, Katzenschlager R, Abela C, Niederle B, Stefenelli T. Effects of successful parathyroidectomy on altered arterial reactivity in patients with hypercalcaemia: results of a 3-year follow-up study. Clin Endocrinol 2000; 53: 229-233
11. Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990 s. Nature 1990; 362: 801-809
12. Bombeli T, Muller M, Haeberli A. Anticoagulant property of the vascular endothelium. Thromb Haemost 1997; 77: 408-423
13. Ross R. Atherosclerosis: an inflammatory disease. N Engl J Med 1999; 340: 115-126
14. Anderson TJ. Assessment and treatment of endothelial dysfunction in humans. J Am Coll Cardiol 1999; 34: 631-638
15. Krieglstein CF, Granger DN. Adhesion molecules and their role in vascular disease. Am J Hypertens 2001; 14: S44-S54
16. Zacharieva S, Atanassova I, Nachev E, Orbetzova M, Kirilov G, Kalinova K, Shigarminova R. Markers of vascular function in hypertension due to Cushing's syndrome. Horm Metab Res 2005; 37: 36-39
17. Schram MT, Stehouwer CDA. Endothelial dysfunction, cellular adhesion molecules and the metabolic syndrome. Horm Metab Res 2005; 37, (Suppl 1): 49-55
18. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 1998; 21 (Suppl 1): S5-S19
19. National Institutes of Health, National Heart, Lung and Blood Institute. Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults: the evidence report. Obes Res 1998; 6 (Suppl 2): S51-S210
20. Cella G, Bellotto F, Tona F, Sbarai A, Mazzaro G, Motta G, Fareed J. Plasma markers of endothelial dysfunction in pulmonary hypertension. Chest 2001; 120: 1226-1230
21. Casonato A, Sartori MT, Pontara E, Zucchetto S, Girolami A. Impaired release of tissue plasminogen activator (t-PA) following DDAVP infusion in von Willebrand factor content. Blood Coagul Fibrinolysis 1992; 3: 149-153
22. Hwang SJ, Ballantyne CM, Sharrett AR, Smith LC, Davis CL, Gotto AM jr, Boerwinckle E. Circulating adhesion molecules VCAM-1, ICAM-1 and E-selectin in carotid atherosclerosis and incident coronary heart disease patients: the Atherosclerosis Risk in Community Study (ARIC). Circulation 1997; 96: 4219-4225
23. Ferri C, Desideri G, Balconcini R, Bellini C, Pasin M, Cantucci A, De Mattia G. Early-up regulation of endothelial adhesion molecule in obese hypertensive men. Hypertension 1999; 34: 568-573
24. Abdu TA, Elhadd T, Pfeifer M, Clayton RN. Endothelial dysfunction in endocrine disease. Trends Endocrinol Metab 2001; 12: 257-265
25. Lufkin EG, Fass DN, O'Fallon WM, Bowie EJW. Increased von Willebrand factor in diabetes mellitus. Metabolism 1979; 28: 63-66
26. Badimon L, Badimon JJ, Chesebro JH, Fuster V. von Willebrand factor and cardiovascular disease. Thromb Haemost 1993; 70: 111-118
27. Smith FB, Lowe GDO, Fowkes FGR, Rumley A, Rumley AG, Donnan PT, Housley E. Smoking, haemostatic factors and lipid peroxides in a population case control study of peripheral arterial disease. Atherosclerosis 1993; 102: 155-162
28. Lim HS, Lip GIH, Blann AD. Plasma von Willebrand factor and the development of the metabolic syndrome in patients with hypertension. J Clin Endocrinol Metab 2004; 89: 5377-5381
29. Hernandez LR, Lundberg U, Arocha-Pinango CL. Experimental thrombosis I: relation with fibrinogen and other haemostatic parameters. Thromb Res 2000; 99: 295-305
30. Takano S, Kimura S, Ohdama S, Aoki N. Plasma thrombomodudulin in health and disease. Blood 1990; 59: 581-591
31. Ishii H, Uchiyama H, Kazama M. Soluble thrombomodulin antigen in conditioned medium is increased by damage of endothelial cells. Thromb Haemost 1991; 65: 618-623
32. Inukai T, Fujiwara Y, Tayama K, Aso Y, Takemura Y. Clinical significance of measurement of urinary and serum thrombomodulin in patients with non-insulin-dependent diabetes mellitus. Diabetes Res Clin Pract 1996; 33: 99-104
33. Mihara H, Murai A, Handa K, Saku K, Shirai K, Tanaka K, Arakawa K. Thrombomodulin levels in patients with coronary artery disease. Artery 1997; 22: 293-308
34. Schumaker A, Seljeflot I, Sommervoll L, Christensen B, Otterstad JE, Arnesen H. Increased levels of endothelial markers in patients with coronary artery disease. Thromb Res 2002; 105: 25-31
35. Martina V, Bruno GA, Brancaleoni V, Zumpano E, Tagliabue M, Fornengo R, Gasparri G, Pescarmona GP. Calcium blood level modulates nitric oxide action: effects of parathyroidectomy in patients with hyperparathyroidism. J Endocrinol 1998; 156: 231-235
36. Massry SG, Iseki K, Campese VM. Serum calcium, parathyroid hormone, and blood pressure. Am J Nephrol 1986; 6 (Suppl 1): 19-28
37. Hatton DC, McCarron DA. Dietary calcium and blood pressure in experimental models of hypertension. Hypertension 1994; 23: 513-530
38. Resnick LA. Calcitropic hormones in human and experimental hypertension. Am J Hypertens 1990; 3: S171-S178
39. Jiang B, Morimoto S, Yang J, Niinobau T, Fukuo K, Ogihara T. Expression of parathyroid hormone/parathyroid hormone-related peptide receptor in vascular endothelial cells. J Cardiovas Pharmacol 1998; 31: S142-S144
40. 2+-regulated secretion of tissue-type plasminogen activator and von Willebrand factor in human endothelial cells. Biochim Biophys Acta 2002; 1600: 162-167
41. Vita JA, Treasure CB, Nabel EG, McLenachan JM, Fish D, Yeung AC, Velkstein VI, Selwin AP, Ganz P. Coronary vasomotor response to acetylcoline relates to risk factors for coronary artery disease. Circulation 1990; 81: 491-497
42. Nilius B, Droogmans G. Ion channels and their functional role in vascular endothelium. Physiol Rev 2001; 81: 1415-1459